Tulsi Gabbard Talks Husband Abraham Williams' Rare Cancer

The Moment the Diagnosis Came

In a video released to CBS News, Tulsi Gabbard described the day her husband, Abraham Williams, learned he had a rare tumor. Williams had been dealing with persistent lower back pain for several weeks. After routine examinations failed to explain the discomfort, doctors ordered advanced imaging that revealed a mass at the base of his spine.

The scan showed a sacral chordoma, a type of cancer that originates in the remnants of the notochord. Gabbard said the news felt "like a punch in the gut" and that the family immediately began researching the disease to understand what lay ahead.

Back pain leads to a medical investigation

Back pain is a common complaint, but when it does not improve with standard treatment, physicians often recommend magnetic resonance imaging (MRI). In Williams' case, the MRI highlighted an abnormal growth that required a biopsy. The biopsy confirmed the presence of a chordoma, a finding that surprised both the patient and his doctors because the tumor is extremely uncommon.

Understanding Sacral Chordoma

Chordomas account for less than 1 percent of all cancers. They typically develop along the spine, most frequently at the base of the skull or the sacrum. The sacral location, as in Williams' case, poses unique challenges because the tumor sits near critical nerves that control bladder, bowel and sexual function.

What makes this tumor rare

According to the National Cancer Institute, chordomas grow slowly but are locally aggressive. Their rarity means that many physicians have limited experience treating them, and research on optimal therapies is still evolving.

Key facts about sacral chordoma include:

Incidence of roughly 0.08 per 100,000 people per year.
Typical age of diagnosis ranges from 40 to 70 years.
Symptoms often include pain, numbness, and loss of bowel or bladder control.

Family Response and Emotional Impact

Gabbard spoke openly about the emotional toll the diagnosis has taken on her family. She described moments of fear, frustration, and hope, noting that the uncertainty of treatment outcomes can be overwhelming.

Support network and coping strategies

The couple leaned on a close circle of friends, former colleagues, and veteran support groups. Gabbard emphasized the importance of mental health resources, saying that counseling and meditation have helped them stay grounded.

She also highlighted the role of public platforms in raising awareness. By sharing their story, the family hopes to connect with others facing similar rare cancers and to encourage early medical evaluation for persistent pain.

Treatment Options and Medical Guidance

Management of sacral chordoma usually involves a combination of surgery, radiation, and, in some cases, targeted therapies. The primary goal is to remove as much of the tumor as possible while preserving nerve function.

Surgery, radiation, and clinical trials

Williams' medical team has recommended a complex surgical procedure followed by proton beam radiation, a technique that delivers high‑energy particles with precision. Proton therapy is often preferred for chordoma because it minimizes damage to surrounding tissue.

In addition to standard treatment, the team is evaluating eligibility for clinical trials that explore new drug combinations. The Mayo Clinic lists several ongoing studies focusing on molecular targets specific to chordoma cells.

Key steps in the treatment plan include:

Pre‑operative imaging to map the tumor’s relationship to nerves.
Surgical resection with the aim of negative margins.
Post‑operative proton beam therapy to reduce recurrence risk.
Regular follow‑up scans to monitor for regrowth.
Consideration of clinical trial enrollment when appropriate.

Public Awareness and Advocacy

By speaking publicly, Gabbard hopes to shine a light on rare cancers that often receive limited attention. She noted that early detection can improve outcomes, especially when symptoms like unexplained back pain are investigated promptly.

Why sharing the story matters

Rare disease advocacy groups rely on personal narratives to attract funding and research interest. The National Organization for Rare Disorders cites patient stories as a catalyst for policy change and increased clinical trial enrollment.

Gabbard also encouraged readers to support organizations that fund chordoma research, noting that every contribution helps advance treatment options for patients worldwide.

The couple’s journey underscores the importance of listening to one’s body, seeking thorough medical evaluation, and staying informed about emerging therapies. As the treatment plan unfolds, Gabbard remains hopeful that sharing their experience will empower others facing similar challenges.